Event Brief
Samsung Biologics buys Swiss peptide maker for $1.8bn
Filed: Jul 20, 2026 at 4:00 AM ET
Summary: Samsung Biologics agreed to acquire Swiss peptide maker PolyPeptide for $1.8 billion.
WHO: Samsung Biologics
WHAT: Samsung Biologics agreed to buy Swiss peptide maker PolyPeptide for $1.8 billion
WHEN: Jul 20, 2026 at 2:53 AM ET
WHERE: Switzerland
WHY: Cause not yet established.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
🔒
This is the public version of this intelligence brief. Sign in to view the original source links, related events, trend evolution, and archive search.
Sign up free →